Serum procalcitonin improves diagnosis of infectious complications after CRS/HIPEC

Lilian Roth1, Dilmurodjon Eshmuminov1, Linda Russo1

  • 1Surgical Oncology Research Laboratory, Department of Surgery & Transplantation, University Hospital of Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.

Insights

Diagnosing infections after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is challenging. Procalcitonin (PCT) aids in identifying infections, but clinical expertise remains crucial for diagnosis.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Critical Care Medicine

Background:

  • Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are vital for patients with peritoneal metastasis.
  • Infection and sepsis are significant causes of morbidity following CRS/HIPEC.
  • HIPEC impacts the accuracy of standard blood markers for diagnosing postoperative complications.

Purpose of the Study:

  • To evaluate the sensitivity and specificity of blood and serum markers for diagnosing postoperative complications after CRS/HIPEC.
  • To determine the utility of white blood cell (WBC) counts, C-reactive protein (CRP), and procalcitonin (PCT) in this context.

Main Methods:

  • Analysis of perioperative blood samples from 248 patients undergoing CRS/HIPEC across two centers (2009-2017).
  • Measurement of WBC, CRP, and PCT levels.
  • Grading of complications using Clavien-Dindo and CDC criteria.

Main Results:

  • White blood cell (WBC) response to infection was suppressed in some patients post-HIPEC.
  • C-reactive protein (CRP) showed non-specific elevations, particularly after prolonged HIPEC (>60 min).
  • Procalcitonin (PCT) demonstrated high specificity, though lower sensitivity, for detecting infectious complications.

Conclusions:

  • Standard markers like WBC counts and CRP have limited diagnostic value for infections after HIPEC.
  • Procalcitonin (PCT) is a useful adjunct for specifying suspected infections.
  • Postoperative complication diagnosis after CRS/HIPEC relies heavily on clinical assessment and surgical experience.
Abstract